Peripheral neuropathy symptoms, pain, and functioning in previously treated multiple myeloma patients treated with selinexor, bortezomib, and dexamethasone.

Authors :: Sanchez L
Leleu X
Beaumont JL
Yu H
Hudgens S
Simonova M
Auner HW
Quach H
Delimpasi S
Špička I
Pour L
Kriachok I
Dimopoulos MA
Usenko G
Hájek R
Benjamin R
Sinha DK
Venner C
Illmer T
Garg MK
Stevens DA
Jagannath S
Levy M
Anderson LD Jr
Bahlis NJ
Facon T
Cavo M
Chai Y
Ma X
Tang S
Leong H
Shah J
Shacham S
Kauffman M
Richardson P
Grosicki S
Source :: American journal of hematology [Am J Hematol] 2021 Oct 01; Vol. 96 (10), pp. E383-E386. Date of Electronic Publication: 2021 Jul 12.
Publication Year :: 2021

Subjects :: Aged
Antineoplastic Combined Chemotherapy Protocols adverse effects
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Bortezomib therapeutic use
Dexamethasone therapeutic use
Female
Humans
Hydrazines therapeutic use
Male
Triazoles therapeutic use
Bortezomib adverse effects
Dexamethasone adverse effects
Hydrazines adverse effects
Multiple Myeloma drug therapy
Pain chemically induced
Peripheral Nervous System Diseases chemically induced
Triazoles adverse effects

Full Text Access

Tools